Streptomyces bingchenggensis produced milbemycins, including a 1 (A 3 ), a 3 (A 4 ), b 13 , b 14 , a 28 , a 29 , a 30 and ST 906, four secomilbemycins A, B, C and D, and two cyclic pentapeptides. [1] [2] [3] [4] [5] Milbemycins belong to a 16-membered macrolide antibiotic with an outstanding activity against various kinds of mites. 6 During a screening program for high production of A 3 and A 4 , a mutant S. bingchenggensis X-4 was obtained by UV treated, N-methyl-N¢-nitroso-N-nitroso-guanidine mutation and genetic manipulative techniques. Significant differences of phenotype, such as the morphology of aerial mycelia, and the metabolite HPLC profiles were observed between the wild-type S. bingchenggensis and its mutant strain X-4. In the course of investigating the metabolites of this mutant strain, three new interesting compounds milbemycin b 15 (1), seco-milbemycins E (2) and F (3) were isolated from the fermentation broth of S. bingchenggensis X-4. The structure of compound 1 was similar with milbemycin D, which is a highly selective and potent nematocide and insecticide. 7 So the bioactivity of compound 1 should be further investigated. Compared with the seco-milbemycins isolated previously, 2,3 the hydroxy groups at C-5 were absent in compounds 2 and 3. Furthermore, all the milbemycins 3,8 and avermectins 9,10 obtained from microorganisms contain the hydroxyl at C-5, and the 5-dehydroxyl derivatives of milbemycins and avermectins can only be obtained using the synthetic methods. 11 So seco-milbemycins E and F may have an important role in understanding and perfecting the proposed biosynthesis pathways of milbemycins.
After incubation for 32 h, the seed broth (3 l) in the 15-l fermentor was transferred into the production 50-l fermentor (FUS-50 L (A), Shanghai Guoqiang Bioengineering Equipment) containing 30-l production medium (16.0% sucrose, 2.0% soybean powder, 0.5% yeast extract, 0.5% meat extract, 0.05% K 2 HPO 4 , 0.05% MgSO 4 7H 2 O, 0.005% FeSO 4 7H 2 O and 0.3% CaCO 3 ). 12 The culture temperature was 28 1C and the initial pH was 7.40 sterilized by sparging with steam at 121 1C for 30 min. The dissolved oxygen was maintained above 35% by adjusting the agitation speed. The initial aeration and agitation rate in the 15-l reactor was 1 vvm and 180 r.p.m., whereas those in the 50 l were 0.8 vvm and 150 r.p.m., respectively. In the process of fermentation, the pH was not controlled. The fermentation was performed for 10 days at 28 1C.
The fermentation broth (30 l) was filtered. The resulting cake was washed with water, and both filtrate and wash were discarded. Methanol (10 l) was used to extract the washed cake. The MeOH extract was evaporated under reduced pressure to B2 l at 45 1C and the resulting concentrate was extracted three times using an equal volume of EtOAc. The combined EtOAc phase was concentrated under reduced pressure to yield 30 g of oily substances. The residual oily substance was chromatographed on silica gel (Qingdao Haiyang Chemical Group, Qingdao, China; 100-200 mesh) and eluted with a petroleum ether-acetone mixture (100:0-50:50, v/v). The fractions eluted with the petroleum ether-acetone mixture (90:10, v/v) were combined and evaporated to obtain fraction I and the fractions eluted with the petroleum ether-acetone mixture (85:15, v/v) were pooled and concentrated to give fraction II. The fraction I was subjected to Sephadex LH-20 (GE Healthcare, Glies, UK) gel column eluting with MeOH to give subfraction I. The semi-preparative HPLC (Agilent 1100, Zorbax SB-C18, 5 mm, 250Â9.4 mm i.d.; Agilent, Palo Alto, CA, USA) was applied to obtain pure compounds. The eluates were monitored using a photodiode array detector at 220 nm, and the flow rates were 1.5 ml min À1 at room temperature. The subfraction I was further separated by semi-preparative HPLC using a solvent containing a CH 3 
), secomilbemycins E (2) and F (3) (coupling constants in parenthesis)
Proton Carbon In compound 1, the large J (14.6 Hz) of H-10 and H-11 and the NOESY crossing peaks (Figure 1 ) between H 2 -27 and H-10, H 3 -29 and H 2 -16 indicated that the three double bonds at C-8 and C-9, C-10 and C-11, C-14 and C-15 were E. The NOESY correlations of H-17, H 3 -30 and H-25, H-17 and H-19, H-11 and H 3 -28 suggested that these protons having the same orientations as in milbemycin b 12 .
From a biogenetic point of view, the relative stereochemistry of the chiral centers in compound 1 was assigned based on that of milbemycin E 14 In compound 2, the NOESY correlations ( Figure 2b ) between H-27 and H-10 and between H-6 and H-9 indicated the D 8 olefin was transdouble bond as in seco-milbemycin C. The E configuration of the D 10 olefin of compound 2 was assigned by the large J (14.9 Hz) between H-10 and H-11. The NOESY correlation signal between H-29 and H-16 revealed that the double bond of C-14 and C-15 was E. Furthermore, the NOESY correlations (Figure 2a ) of H-17, H 3 -30 and H-25, H-17 and H-19, H-10 and H 3 -28 showed the orientation of these protons. Thus, the structure of compound 2 was established. Biogenetically, the relative stereochemistry of the chiral centers in compound 2 was assigned based on that of seco-milbemycin C. (Table 1) were very similar to those of compound 2. Comparison of the 1 H and 13 C NMR data of compound 3 with those of compound 2, suggested that compound 3 was structurally related to compound 2. The difference between compounds 3 and 2 could be explained by the replacement of a methyl substituent in C-25 in compound 2 by an ethyl group in compound 3. The stereostructure of compound 3 was assigned as that of compound 2 by the analysis of the NMR data and NOESY correlation signals (Figure 2b ). Further comparison of the NMR data with those of seco-milbemycin A (compound 5, Figure 2a ) 2 confirmed the structure assignment of compound 3.
The acaricidal activity against adult two-spotted spider mites (Tetranychus urticae Koch) and mite eggs as well as nematocidal activity against Caenorhabditis elegans of compounds 1, 2 and 3 were evaluated according to the methods described previously. 1, 4, 5 Although these compounds showed potent acaricidal and nematocidal activities (data not shown), the bioactivities were weaker than those of the commercial acaricide and nematocide milbemycins A 3 / A 4 . However, the discovery of compounds 1, 2 and 3 in the mutant S. bingchenggensis X-4 may shed new insight into the biosynthesis of milbemycin.
